Today: 19 May 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 28.02.2026

LIVEMarkets rolling coverageStarted: February 28, 2026, 12:00 AM ESTUpdated: February 28, 2026, 11:59 PM EST Hilton Worldwide Holdings (HLT) Valuation Assessment After Recent Share Gains February 28, 2026, 11:52 PM EST. Hilton Worldwide Holdings (HLT) shares have climbed 4.4% over the past month, closing at $311.78, with a 3-month gain of 10.2%. Despite short-term dips, the stock shows resilient momentum with a 1-year total shareholder return near 18%. Analysts peg its fair value slightly higher at $328.28, suggesting a 5% undervaluation. Hilton operates an asset-light model focusing on management and franchise agreements, driving revenue growth and higher net margins while
28 February 2026
Analog Devices stock dodges chip selloff as insider sale hits tape; jobs report next

Analog Devices stock dodges chip selloff as insider sale hits tape; jobs report next

Analog Devices shares closed up 0.37% at $355.67 Friday, outperforming chip peers as the S&P 500 and Nasdaq fell. Chief accounting officer Michael Sondel sold about $1.52 million in stock earlier in the week, according to an SEC filing. The company recently forecast Q2 revenue above analyst estimates. Broader chip stocks slid after a hotter-than-expected inflation reading.
28 February 2026
··
Chevron stock price rises as oil rallies; OPEC+ meeting and Lukoil talks loom

Chevron stock price rises as oil rallies; OPEC+ meeting and Lukoil talks loom

Chevron shares rose 1.41% to $186.76 Friday, tracking gains in crude after U.S.-Iran nuclear talks ended without a deal. Washington extended the deadline for bids on Lukoil’s assets to April 1, with Chevron and Quantum Capital Group in talks for the $22 billion portfolio. Brent crude settled up 2.45% at $72.48 a barrel. The S&P 500 fell 0.43% and the Dow dropped 1.05%.
28 February 2026
·····
Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears

Eli Lilly shares rose 2.93% to $1,051.99 Friday, outperforming a falling market. Full results from a diabetes trial showed Lilly’s oral drug orforglipron caused more nausea and discontinuations than Novo Nordisk’s Rybelsus, but produced greater A1C and weight reduction. The 52-week study involved 1,698 patients. Novo plans to cut U.S. list prices for Ozempic and Wegovy by up to 50% starting in 2027.
28 February 2026
···
FTAI Aviation stock slips into the weekend after earnings miss — here’s what matters for Monday

FTAI Aviation stock slips into the weekend after earnings miss — here’s what matters for Monday

FTAI Aviation shares fell 1.4% to $305.80 Friday after missing quarterly earnings estimates but raising its 2026 adjusted EBITDA forecast and boosting its dividend to $0.40 a share. The company reported Q4 revenue of $662 million and EPS of $1.09, both below Wall Street expectations. FTAI’s annual filing noted eight aircraft and 17 engines remain in Russia and warned operating cash flow has lagged shareholder distributions.
28 February 2026
··
Citigroup stock sinks after-hours as credit jitters hit banks, even after BlackRock deal

Citigroup stock sinks after-hours as credit jitters hit banks, even after BlackRock deal

Citigroup shares fell 4.5% to $110.19 in after-hours trading Friday, following a broad selloff in U.S. bank stocks. The drop came after the collapse of UK mortgage provider Market Financial Solutions revived concerns about private credit risks and persistent inflation dampened hopes for Fed rate cuts. About 18 million Citi shares changed hands. The S&P 500 bank index slid roughly 4%.
28 February 2026
··
Salesforce stock price slips after hours: $50B buyback, Agentforce AI and what Wall Street watches next

Salesforce stock price slips after hours: $50B buyback, Agentforce AI and what Wall Street watches next

Salesforce shares fell 2.35% to $194.79 Friday and edged lower after hours. The company forecast fiscal 2027 revenue slightly below analyst expectations and announced a $50 billion buyback. Stifel and DA Davidson cut price targets, citing concerns over AI adoption and slower growth in older products. Investors are watching next week’s U.S. jobs report for broader tech market signals.
28 February 2026
····
Bank of America stock sinks nearly 5% as bank rout hits Wall Street — what to watch next

Bank of America stock sinks nearly 5% as bank rout hits Wall Street — what to watch next

Bank of America shares dropped 4.7% to $49.83 Friday, losing $2.47 as U.S. bank stocks slid after the collapse of UK lender Market Financial Solutions fueled credit concerns. About 77.7 million shares traded. U.S. producer prices rose more than expected in January, reinforcing bets the Federal Reserve will keep rates steady. The 10-year Treasury yield eased to 3.95%.
28 February 2026
·
JPMorgan stock slides after hours as private-credit jitters drag U.S. banks

JPMorgan stock slides after hours as private-credit jitters drag U.S. banks

JPMorgan shares fell 4.2% to $300.30 in after-hours trading Friday, leading a sharp selloff in U.S. bank stocks. Renewed fears over credit losses from private-credit deals and the collapse of UK lender Market Financial Solutions rattled investors. A lawsuit also hit JPMorgan over alleged fraud in auto loan-backed securities. Traders now await the March 6 U.S. jobs report for rate signals.
28 February 2026
·
Lumentum stock price rebounds after Thursday slide as Form 144 sale notice hits tape

Lumentum stock price rebounds after Thursday slide as Form 144 sale notice hits tape

Lumentum shares rose 3.5% to $700.91 Friday, rebounding after a 6.4% drop Thursday, with heavy trading and wide price swings. A new SEC Form 144 filing showed Morgan Stanley Smith Barney plans to sell 5,302 shares worth about $3.66 million. Investors are watching management’s upcoming conference appearances for signals on AI data-center demand. The S&P 500 and Nasdaq both fell on the day.
28 February 2026
··
Booking (BKNG) stock price slips as March split and dividend dates tighten the calendar

Booking (BKNG) stock price slips as March split and dividend dates tighten the calendar

Booking Holdings shares fell 0.26% to $4,239.35 Friday as the company announced a 25-for-1 stock split, with new shares distributed after April 2. The board declared a $10.50 per share dividend payable March 31. Executives reported lower average daily rates and shorter stays in the U.S. Travel stocks broadly declined, with Expedia and TripAdvisor also closing lower.
28 February 2026
····
Alphabet GOOG stock price rises on Meta AI chip deal, then slips after hours amid new Google ads probe

Alphabet GOOG stock price rises on Meta AI chip deal, then slips after hours amid new Google ads probe

Alphabet shares rose 1.4% Friday after reports Meta signed a multi-year deal to rent Google’s AI chips, then slipped 0.5% in after-hours trading. Belgium’s competition authority opened a preliminary antitrust probe into Google’s online ad sales. Alphabet’s trading volume hit 33 million shares, above its 50-day average. The company forecast 2026 capital expenditures could reach up to $185 billion.
28 February 2026
··
CoreWeave stock price tumbles as $35 billion capex plan rattles investors

CoreWeave stock price tumbles as $35 billion capex plan rattles investors

CoreWeave shares fell 18.5% to $79.53 after the company announced 2026 capital spending of $30–$35 billion, more than double last year’s outlay. The AI cloud firm reported a Q4 net loss of $452 million on $1.57 billion in revenue, citing short-term margin pressure as it accelerates data center expansion. Investors remain focused on funding and profitability ahead of management’s updates next week.
28 February 2026
··
Bitcoin price slides toward $65,000 late Friday as rate-cut bets wobble

Bitcoin price slides toward $65,000 late Friday as rate-cut bets wobble

Bitcoin fell 2.8% to $65,479 in late U.S. trading Friday, after hitting an intraday high of $68,118 and briefly touching $65,202. The drop followed a hotter-than-expected U.S. producer price index, which rose 0.5% in January. Spot bitcoin ETFs saw net inflows of $506.6 million and $254.4 million on Feb. 25 and 26, led by BlackRock’s iShares Bitcoin Trust, according to Farside Investors.
27 February 2026
·
Dell stock jumps 22% on AI server outlook and $10 billion buyback — what Wall Street watches next

Dell stock jumps 22% on AI server outlook and $10 billion buyback — what Wall Street watches next

Dell shares jumped 21.9% to $148.08 at Friday’s close, then slipped 0.4% after hours. The company expects AI server revenue to more than double to $50 billion by fiscal 2027 and raised its dividend 20%, adding $10 billion to its buyback program. At least seven brokerages raised price targets after the earnings report. Investors now await the March 6 U.S. jobs report.
27 February 2026
·
Meta stock slips after hours as Google AI chip rental report and EU legal setback keep costs in focus

Meta stock slips after hours as Google AI chip rental report and EU legal setback keep costs in focus

Meta shares fell 2.8% to $648.18 in after-hours trading Friday after reports the company signed a multi-year deal to rent Google’s AI chips. The White House plans to meet with major AI firms next week to discuss electricity costs tied to data centers. An EU court adviser backed regulators seeking information in antitrust probes involving Meta. Louisiana utility regulators denied a request to investigate a $27 billion Meta data center deal.
27 February 2026
···
1 … 191 192 193 194 195 … 1,952

Stock Market Today

  • 5 TSX Dividend Stocks Yielding 3% to 5% for Reliable Cash Flow
    May 18, 2026, 10:18 PM EDT. Building a portfolio of TSX dividend stocks can deliver steady income and market resilience. Top picks include Enbridge (TSX:ENB), an energy infrastructure giant offering a 5.1% yield backed by decades of consistent dividend growth. RioCan REIT (TSX:REI.UN) provides a unique monthly dividend of 5.4%, combining commercial real estate and residential exposure in Canadian metros. Toronto-Dominion Bank (TSX:TD) stands out among big banks with a 2.9% yield, nearly two centuries of dividends, and strong U.S. growth. These selections cover varied sectors and offer investors dependable cash flow with defensive qualities amid market volatility.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Why Virax Biolabs Stock Is Jumping Before the Bell Today

Why Virax Biolabs Stock Is Jumping Before the Bell Today

18 May 2026
Virax Biolabs shares jumped in pre-market trading Monday, indicated at $0.3458 after closing Friday at $0.1535. The move followed a sponsored TV segment featuring CEO James Foster and a new SEC filing showing Armistice Capital holds 4.99% of shares. ViraxImmune, the company’s main test, remains in development and is not approved for diagnostic use. No new company press release appeared over the weekend.
Go toTop